PIM1 and pachyonychia congenita: Moreover, serine/threonine (PIM‐1), a proto‐oncogene, is vital in cell proliferation, and studies have proved that PIM‐1 kinase is involved in cellular development, immunoregulation, and oncogenesis; therefore, it is an appropriate therapeutic target for PC (Imada et al. 2021).